The initial success of the copyright undeniably reshaped the pharmaceutical landscape, but placing funds in companies heavily reliant on unbranded versions presents a challenging website picture. Although early profits were impressive, the cessation of patents and the rise of cheaper alternatives have eroded sales. Thus, a thorough assessment of cu